Market Overview:
The global small intestinal submucosa (SIS) market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The wound dressing segment is expected to dominate the market in terms of value, and is projected to grow at a CAGR of 8.1%. The implant material segment is projected to grow at the highest CAGR of 9.0%. In terms of application, medical applications are estimated to account for majority share in 2018 and are anticipated to maintain its dominance throughout the forecast period. However, beauty applications are expected witness highest growth rate over the forecast period owing high adoption rates in developed countries such as U.S.
Product Definition:
The small intestinal submucosa (SIS) is a layer of connective tissue that lines the small intestine and helps to support its functions. The SIS contains blood vessels, nerves, and other cells that help to keep the small intestine healthy.
Wound Dressing:
Wound dressing is a process of protecting and healing the wound. The main function of wound dressings is to help stop exudation (the flow of body fluids from the site of injury) and maintain a moist environment around the affected area. There are two types of wound dressings: first-aid type which includes gauze, tape & bandages; second-aid type which includes hydrogel, alginate & foam dressings.
Implant Material:
Implant material is used in the treatment of damaged intestinal mucosa. The most common cause of damage to the small intestine is due to Crohn's disease or ulcerative colitis. Other causes include radiation therapy, surgery, and autoimmune disorders such as Celiac disease or gluten-sensitive enteropathy.
The implant material helps replace the damaged submucosa and aids in healing & regenerating new tissue growth along with reducing inflammation & pain caused by affected areas.
Application Insights:
Medical application dominated the global small intestinal submucosa (SIS) market in 2017, accounting for over 60.0% share of the overall revenue. This segment is expected to witness significant growth during the forecast period owing to rising incidences of chronic diseases such as diabetes and cancer across various regions. As per capita income increases, prevalence of these diseases also goes up resulting in higher demand for advanced therapies which further drives market growth.
The beauty segment is expected to exhibit a high CAGR during the forecast period owing to increasing number of aesthetic surgeries being performed on a regular basis especially in developed regions like North America and Europe. Moreover, growing preference towards minimally invasive procedures will boost product demand over the coming years as it provides better access to smaller areas thus reducing postoperative pain and swelling more efficiently than conventional surgeries do.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of local and international companies. The region is expected to maintain its dominance over the forecast period due to factors such as favorable reimbursement policies, increasing prevalence of diabetes and obesity, rising awareness about SIS treatment options, availability & accessibility of healthcare services & products, and high disposable income.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in diabetic patients suffering from small intestinal disorders coupled with growing medical tourism industry in emerging countries such as China & India. In addition, an increase in per capita healthcare expenditure by governments along with rising investments by private firms will boost regional growth further. For instance; In May 2018; Becton Dickinson And Company (BD) announced that it has entered into a joint venture agreement with Zhejiang Gudian Medical Co., Ltd., China for establishing BD-Gudi’s Surgical Industrial Park (SIP).
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the advantages offered by these surgeries over traditional open surgery, such as shorter hospital stays, reduced pain and blood loss, and faster recovery times. Small intestinal submucosa (SIS) has emerged as an important biomaterial for use in minimally invasive surgeries due to its favorable properties such as biocompatibility, non-toxicity, and ease of handling.
- Growing prevalence of gastrointestinal diseases: The incidence of gastrointestinal diseases is increasing globally due to changing lifestyles and dietary habits. This has led to an increase in the demand for effective treatments for these diseases. Small intestinal submucosa (SIS) has been found to be effective in the treatment of various gastrointestinal disorders such as Crohn’s disease, ulcerative colitis, gastric ulcers, and Barrett’s esophagus.
- Rising awareness about benefits of small intestine submucosa: There is growing awareness among surgeons about the benefits of small intestine submucosa (SIS) as a biomaterial for use in surgical procedures. This is helping drive its adoption across different surgical applications worldwide..
Scope Of The Report
Report Attributes
Report Details
Report Title
Small Intestinal Submucosa (SIS) Market Research Report
By Type
Wound Dressing, Implant Material, Other
By Application
Medical, Beauty, Other
By Companies
Cook Group, Beijing Biosis Healing Biological Technology Co.,Ltd, H&R Healthcare, Vetrix, Inc., BiologiQ, Avalon Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
170
Number of Tables & Figures
119
Customization Available
Yes, the report can be customized as per your need.
Global Small Intestinal Submucosa (SIS) Market Report Segments:
The global Small Intestinal Submucosa (SIS) market is segmented on the basis of:
Types
Wound Dressing, Implant Material, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical, Beauty, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cook Group
- Beijing Biosis Healing Biological Technology Co.,Ltd
- H&R Healthcare
- Vetrix, Inc.
- BiologiQ
- Avalon Medical
Highlights of The Small Intestinal Submucosa (SIS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wound Dressing
- Implant Material
- Other
- By Application:
- Medical
- Beauty
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Small Intestinal Submucosa (SIS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Small intestinal submucosa is a type of mucous membrane that lines the small intestine. It helps to absorb nutrients and water from food.
Some of the major companies in the small intestinal submucosa (sis) market are Cook Group, Beijing Biosis Healing Biological Technology Co.,Ltd, H&R Healthcare, Vetrix, Inc., BiologiQ, Avalon Medical.
The small intestinal submucosa (sis) market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Small Intestinal Submucosa (SIS) Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Small Intestinal Submucosa (SIS) Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Small Intestinal Submucosa (SIS) Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Small Intestinal Submucosa (SIS) Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Small Intestinal Submucosa (SIS) Market Size & Forecast, 2018-2028 4.5.1 Small Intestinal Submucosa (SIS) Market Size and Y-o-Y Growth 4.5.2 Small Intestinal Submucosa (SIS) Market Absolute $ Opportunity
Chapter 5 Global Small Intestinal Submucosa (SIS) Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Small Intestinal Submucosa (SIS) Market Size Forecast by Type
5.2.1 Wound Dressing
5.2.2 Implant Material
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Small Intestinal Submucosa (SIS) Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Small Intestinal Submucosa (SIS) Market Size Forecast by Applications
6.2.1 Medical
6.2.2 Beauty
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Small Intestinal Submucosa (SIS) Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Small Intestinal Submucosa (SIS) Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Small Intestinal Submucosa (SIS) Analysis and Forecast
9.1 Introduction
9.2 North America Small Intestinal Submucosa (SIS) Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Small Intestinal Submucosa (SIS) Market Size Forecast by Type
9.6.1 Wound Dressing
9.6.2 Implant Material
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Small Intestinal Submucosa (SIS) Market Size Forecast by Applications
9.10.1 Medical
9.10.2 Beauty
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Small Intestinal Submucosa (SIS) Analysis and Forecast
10.1 Introduction
10.2 Europe Small Intestinal Submucosa (SIS) Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Small Intestinal Submucosa (SIS) Market Size Forecast by Type
10.6.1 Wound Dressing
10.6.2 Implant Material
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Small Intestinal Submucosa (SIS) Market Size Forecast by Applications
10.10.1 Medical
10.10.2 Beauty
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Small Intestinal Submucosa (SIS) Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Small Intestinal Submucosa (SIS) Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Small Intestinal Submucosa (SIS) Market Size Forecast by Type
11.6.1 Wound Dressing
11.6.2 Implant Material
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Small Intestinal Submucosa (SIS) Market Size Forecast by Applications
11.10.1 Medical
11.10.2 Beauty
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Small Intestinal Submucosa (SIS) Analysis and Forecast
12.1 Introduction
12.2 Latin America Small Intestinal Submucosa (SIS) Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Small Intestinal Submucosa (SIS) Market Size Forecast by Type
12.6.1 Wound Dressing
12.6.2 Implant Material
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Small Intestinal Submucosa (SIS) Market Size Forecast by Applications
12.10.1 Medical
12.10.2 Beauty
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Small Intestinal Submucosa (SIS) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Small Intestinal Submucosa (SIS) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Small Intestinal Submucosa (SIS) Market Size Forecast by Type
13.6.1 Wound Dressing
13.6.2 Implant Material
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Small Intestinal Submucosa (SIS) Market Size Forecast by Applications
13.10.1 Medical
13.10.2 Beauty
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Small Intestinal Submucosa (SIS) Market: Competitive Dashboard
14.2 Global Small Intestinal Submucosa (SIS) Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Cook Group
14.3.2 Beijing Biosis Healing Biological Technology Co.,Ltd
14.3.3 H&R Healthcare
14.3.4 Vetrix, Inc.
14.3.5 BiologiQ
14.3.6 Avalon Medical